Baillie Gifford's position in Oscar Health is currently worth $16.3 Million. That's 0.01% of their equity portfolio (191st largest holding). The first Oscar Health trade was made in Q1 2021. Since then Baillie Gifford bought shares four more times and sold shares on six occasions. The investor's estimated purchase price is $18.9 Million, resulting in a loss of 14%.